Table 1. Percent of total CD4+ MLN lymphocytes expressing cell surface activation markers.
Activation Marker | wt TNF+/+ MLN | TNFΔARE/+ MLN | TNFiΔARE/ iΔARE MLN | TNFiΔARE/ iΔARE LP |
---|---|---|---|---|
(P-value vs. wt) | (P-value vs. wt) | (P-value vs. wt) | ||
CD69+ | 14.32 ± 1.67 | 32.05 ± 5.63 | 33.74 ± 1.54 | 74.70 ± 1.70 |
(0.043) | (0.021) | (0.021) | ||
CD62L- | 11.19 ± 0.93 | 28.18 ± 4.11 | 37.17 ± 0.44 | 92.13 ± 0.85 |
(0.021) | (0.021) | (0.021) | ||
CD25+ | 11.57 ± 0.70 | 29.66 ± 2.41 | 25.04 ± 1.22 | 48.72 ± 0.96 |
(0.021) | (0.021) | (0.021) |
Immunophenotypic characterization of mucosal lymphocytes from TNFi∆ARE/i∆ARE mice with ileitis. Single cell suspensions were obtained from MLNs and small intestinal LP. The expression of various surface markers was analyzed by flow cytometry. Fluorochrome-tagged monoclonal antibodies against CD4, CD69, CD25, and CD62L were utilized for identification of the respective populations. Multiple color flow cytometry was performed on a FACS calibur system to determine the percentage of cells expressing surface markers and the intensity of expression. A significant increase was observed in the proportion of mucosal (MLN and LP) CD4+ cells that expressed various markers of activation. The percentages of CD4+ cells expressing CD69 or CD25, or lacking expression of CD62L, were significantly elevated in the MLNs of TNFi∆ARE/i∆ARE mice in comparison to wt controls (P<0.05), whereas no differences were seen between intestinal TNFi∆ARE/i∆ARE and systemic TNFΔARE/+ mice. The largest percentages of CD4+ lymphocytes expressing markers of activation were detected in freshly isolate LP mononuclear cells from TNFi∆ARE/i∆ARE mice. Mice were processed individually. Three separate experiments with 4 mice per group gave similar results. Data are represented as mean values ± SEM for each group of mice.